Oramed Pharmaceuticals
ORMP
#9127
Rank
NZ$0.19 B
Marketcap
NZ$4.96
Share price
1.42%
Change (1 day)
14.77%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$26.23 Million a decrease over its 2023 earnings that were of NZ$12.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-476.87%
2024 -NZ$26.23 Million-311.47%
2023 NZ$12.4 M-119.45%
2022 -NZ$63.77 Million39.17%
2021 -NZ$45.82 Million73.93%
2020 -NZ$26.35 Million18.53%
2019 -NZ$22.23 Million-16.62%
2018 -NZ$26.66 Million38.32%
2017 -NZ$19.27 Million12.51%
2016 -NZ$17.13 Million25.01%
2015 -NZ$13.71 Million18.18%
2014 -NZ$11.6 Million39.72%
2013 -NZ$8.3 Million46.4%
2012 -NZ$5.67 Million128.32%
2011 -NZ$2.49 Million-51.47%
2010 -NZ$5.12 Million35.21%
2009 -NZ$3.79 Million
2007 -NZ$5.95 Million607.04%
2006 -NZ$0.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$36.28 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$15.84 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-NZ$47.98 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA